Economic evaluation favours physiotherapy but not corticosteroid injection as a first-line intervention for chronic lateral epicondylalgia: evidence from a randomised clinical trial

被引:25
作者
Coombes, Brooke K. [1 ,2 ]
Connelly, Luke [3 ]
Bisset, Leanne [4 ]
Vicenzino, Bill [2 ]
机构
[1] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Hlth & Rehabil Sci, Physiotherapy, Brisbane, Qld, Australia
[3] Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld, Australia
[4] Griffith Univ, Menzies Inst, Gold Coast, Qld, Australia
基金
英国医学研究理事会;
关键词
COST-EFFECTIVENESS ANALYSIS; TENNIS ELBOW; PRIMARY-CARE; POPULATION; TENDINOPATHY; PREVALENCE; MANAGEMENT; UTILITY;
D O I
10.1136/bjsports-2015-094729
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Aim To determine the cost-effectiveness of corticosteroid injection, physiotherapy and a combination of these interventions, compared to a reference group receiving a blinded placebo injection. Methods 165 adults with unilateral lateral epicondylalgia of longer than 6 weeks duration from Brisbane, Australia, were randomised for concealed allocation to saline injection (placebo), corticosteroid injection, saline injection plus physiotherapy (eight sessions of elbow manipulation and exercise) or corticosteroid injection plus physiotherapy. Costs to society and health-related quality of life (estimated by EuroQol-5D) over the 1 year follow-up were used to generate incremental cost per quality-adjusted life year (QALY) ratios for each intervention relative to placebo. Results Intention-to-treat analysis was possible for 154 (93%) of trial participants. Physiotherapy was more costly, but was the only intervention that produced a statistically significant improvement in quality of life relative to placebo (MD, 95% CI 0.035, 0.003 to 0.068). Similar cost/QALY ratios were found for physiotherapy ($A29 343; GBP18 962) and corticosteroid injection ($A31 750; GBP20 518); however, the probability of being more cost-effective than placebo at values above $ A50 000 per quality-adjusted life year was 81% for physiotherapy and 53% for corticosteroid injection. Cost/QALY was far greater for a combination of corticosteroid injection and physiotherapy ($A228 000; GBP147 340). Summary Physiotherapy was a cost-effective treatment for lateral epicondylalgia. Corticosteroid injection was associated with greater variability, and a lower probability of being cost-effective if a willingness to pay threshold of $ A50 000 is assumed. A combination of corticosteroid injection and physiotherapy was ineffective and cost-ineffective. Physiotherapy, not corticosteroid injection, should be considered as a first-line intervention for lateral epicondylalgia.
引用
收藏
页码:1400 / +
页数:7
相关论文
共 28 条
[21]  
Smidt N, 2006, J RHEUMATOL, V33, P2053
[22]   Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine [J].
Smith, Kenneth J. ;
Wateska, Angela R. ;
Nowalk, Mary Patricia ;
Raymund, Mahlon ;
Nuorti, J. Pekka ;
Zimmerman, Richard K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (08) :804-812
[23]   Cost effectiveness of brace, physiotherapy, or both for treatment of tennis elbow [J].
Struijs, P. A. A. ;
Korthals-de Bos, I. B. C. ;
van Tulder, M. W. ;
van Dijk, C. N. ;
Bouter, L. M. ;
Assendelft, W. J. J. .
BRITISH JOURNAL OF SPORTS MEDICINE, 2006, 40 (07) :637-643
[24]   Corticosteroid and platelet-rich plasma injection therapy in tennis elbow (lateral epicondylalgia): a survey of current UK specialist practice and a call for clinical guidelines [J].
Titchener, Andrew G. ;
Booker, Simon J. ;
Bhamber, Nivraj S. ;
Tambe, Amol A. ;
Clark, David I. .
BRITISH JOURNAL OF SPORTS MEDICINE, 2015, 49 (21) :1410-1413
[25]   Prevalence and impact of musculoskeletal disorders of the upper limb in the general population [J].
Walker-Bone, K ;
Palmer, KT ;
Reading, I ;
Coggon, D ;
Cooper, C .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (04) :642-651
[26]   Occupation and epicondylitis: a population-based study [J].
Walker-Bone, Karen ;
Palmer, Keith T. ;
Reading, Isabel ;
Coggon, David ;
Cooper, Cyrus .
RHEUMATOLOGY, 2012, 51 (02) :305-310
[27]   Exploring the cost-utility of stratified primary care management for low back pain compared with current best practice within risk-defined subgroups [J].
Whitehurst, David G. T. ;
Bryan, Stirling ;
Lewis, Martyn ;
Hill, Jonathan ;
Hay, Elaine M. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) :1796-1802
[28]  
World Health Organization (WHO), 2014, THRESH VAL INT COST